Screener
Tectonic Therapeutics TECX Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest income | 2,181 | 2,444 |
| Interest expense | (8) | (20) |
| Other expense | (113) | (32) |
| Total other income, net | 2,060 | 2,392 |
| Net loss | (25,241) | (15,906) |
| Other comprehensive loss: | ||
| Foreign currency translation adjustment | 37 | (7) |
| Comprehensive loss | $(25,204) | $(15,913) |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's other income (expense)?
- Tectonic Therapeutics (TECX) reported other income (expense) of $2.06M in Q1 2026.
- How has Tectonic Therapeutics's other income (expense) changed year-over-year?
- Tectonic Therapeutics's other income (expense) decreased by 13.9% year-over-year, from $2.39M to $2.06M.
- What is the long-term trend for Tectonic Therapeutics's other income (expense)?
- Over 3 years (2021 to 2025), Tectonic Therapeutics's other income (expense) has grown at a 239.1% compound annual growth rate (CAGR), from -$285K to $11.12M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Tectonic Therapeutics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude